Dewo - Question - From the fact that 1/3 of US women have had at least a partial hysterectomy by the time they are 60 it sounds like the medical establishment views the procedure as pretty benign. Perhaps not like tonsillectomy of 30 years ago but close.
So, the question: is the medical community (particularly the doctors prescribing hysterectomy) or the FDA going to consider a drug treatment like Proellex to be more lifestyle (given the 'benign' alternative) than really medical necessary or a valid choice? Obviously it will not be in the same class as Vasomax - but where on the spectrum this fits bears on:
a) what safety the FDA will require? - directly or obliquely
b) whether there is a doctor community that can be targeted for this - or is it going to hit prescribing docs in the pocket book? (I do not mean to accuse docs of consciously choosing to hurt patients for $, but human nature ties to align our goodness and light with our self interest.)
PS I am sure aka is turning flips over this (apologies) - but I am intentionally asking questions, even if a little obscure, that others are not mainstream.
Market Data 
Markets 
AI
